Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
BRIDGEWATER, N.J., December 6, 2024 (Ecnetnews.com) - Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to ...